Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

February 2013
Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
15 Jan 2013 - 21 Feb 2013
Live-on-the-web
LC/MS Fundamentals and Applications
More information
2nd Novel Immunotherapeutics Summit
30 Jan 2013 - 01 Feb 2013
San Diego, CA, USA
2nd Novel Immunotherapeutics Summit
More information
 2nd Allergy & Respitory  Drug Discovery
31 Jan 2013 - 01 Feb 2013
San Diego, CA, USA
2nd Allergy & Respitory Drug Discovery
More information
5th ImmunoTherapeutics & ImmunoMonitoring
31 Jan 2013 - 01 Feb 2013
San Diego, CA, USA
5th ImmunoTherapeutics & ImmunoMonitoring
More information
11th Cytokines and Inflammation Conference
31 Jan 2013 - 01 Feb 2013
San Diego, CA, USA
11th Cytokines and Inflammation Conference
More information
31 Jan 2013 - 01 Feb 2013
TATAA Biocenter, Odinsgatan 28, Gothenburg
2 days Experimental design and data analysis
More information
BioConference Live Laboratory Animal Sciences
13 Feb 2013 - 14 Feb 2013
Online event
BioConference Live Laboratory Animal Sciences
More information




SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!